Revised: 31 May 2019

Medicines

 

Medsafe Product Detail

Data Sheet
File ref: TT50-5539/1
Trade NameDose FormStrengthIdentifier
Potassium chloride 30mmol in 5% GlucoseSolution for infusion30 mmol/LViaflex
SponsorApplication dateRegistration situationClassification
Baxter Healthcare Ltd
P O Box 14062
Panmure
AUCKLAND 1741
29/9/1980Consent given
Approval date: 29/9/1980
General sale
 

Composition

ComponentIngredientManufacturer
solution for infusionActive 
 Glucose 5%
 Potassium chloride 0.224%

Production

Manufacturing stepManufacturer
Finished Product TestingBaxter Healthcare Pty Ltd
1 Baxter Drive
Old Toongabbie
NSW 2146
AUSTRALIA
Manufacture of Final Dose FormBaxter Healthcare Pty Ltd
1 Baxter Drive
Old Toongabbie
NSW 2146
AUSTRALIA
PackingBaxter Healthcare Pty Ltd
1 Baxter Drive
Old Toongabbie
NSW 2146
AUSTRALIA
NZ Site of Product ReleaseBaxter Healthcare Ltd
33 Vestey Drive
Mt Wellington
AUCKLAND

Packaging

PackageContentsShelf Life
Bag, plastic, 1000 mL24 months from date of manufacture stored at or below 30°C

Indications

Potassium chloride and Glucose IV infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of potassium and chloride ion concentrations. This is also an alternative route of administration for patients who are unable to take potassium orally or if hypokalaemia is severe. It may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

Latest Regulatory Activity

Application DateApplication TypeChange(s)StatusPayment DatePriority
4/7/2023Changed Medicine NotificationFinished product specifications/test methods - G2; Administrative fee (CMN)Granted 3/11/202329/8/2023 
Hide menus
Show menus
0 1 2 4 5 6 7 9 [ /